JP2015509956A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509956A5 JP2015509956A5 JP2014560007A JP2014560007A JP2015509956A5 JP 2015509956 A5 JP2015509956 A5 JP 2015509956A5 JP 2014560007 A JP2014560007 A JP 2014560007A JP 2014560007 A JP2014560007 A JP 2014560007A JP 2015509956 A5 JP2015509956 A5 JP 2015509956A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- pyrano
- methylimidazo
- alkyl
- diazepan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 37
- -1 dihydrochloride Chemical compound 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 16
- 125000003282 alkyl amino group Chemical group 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 208000002320 spinal muscular atrophy Diseases 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 210000005260 human cell Anatomy 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 2
- NRGKFNDKBDBBGY-UHFFFAOYSA-N 1h-pyridin-2-one;hydrochloride Chemical compound Cl.O=C1C=CC=CN1 NRGKFNDKBDBBGY-UHFFFAOYSA-N 0.000 claims 1
- NZENVGLXUGPMPT-UHFFFAOYSA-N 3-(1,3-benzothiazol-2-yl)-7-[4-(2,3-dihydroxypropyl)piperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(CC(O)CO)CCN1C1=CC=C(C=C(C=2SC3=CC=CC=C3N=2)C(=O)O2)C2=N1 NZENVGLXUGPMPT-UHFFFAOYSA-N 0.000 claims 1
- LKXICZSEPWWLQQ-UHFFFAOYSA-N 3-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-7-(4-methylpiperazin-1-yl)pyrano[3,2-c]pyridin-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC2=C1C=C(C=1N=C3SC(C)=CN3C=1)C(=O)O2 LKXICZSEPWWLQQ-UHFFFAOYSA-N 0.000 claims 1
- SSNAMLPQNIRTMQ-UHFFFAOYSA-N 3-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-7-piperazin-1-ylpyrano[3,2-c]pyridin-2-one;hydrochloride Chemical compound Cl.N1=C2SC(C)=CN2C=C1C(C(OC1=C2)=O)=CC1=CN=C2N1CCNCC1 SSNAMLPQNIRTMQ-UHFFFAOYSA-N 0.000 claims 1
- UPLNJBCPADXPTR-UHFFFAOYSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-(4-methylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(C=2SC3=CC=CC(Cl)=C3N=2)C(=O)O2)C2=N1 UPLNJBCPADXPTR-UHFFFAOYSA-N 0.000 claims 1
- BJTWRFQYGSHACL-UHFFFAOYSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-(4-propan-2-ylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C(C)C)CCN1C1=CC=C(C=C(C=2SC3=CC=CC(Cl)=C3N=2)C(=O)O2)C2=N1 BJTWRFQYGSHACL-UHFFFAOYSA-N 0.000 claims 1
- INBDEJSJRQLYPF-QWHCGFSZSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-[(2r,5s)-2,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2SC3=CC=CC(Cl)=C3N=2)C(=O)O2)C2=N1 INBDEJSJRQLYPF-QWHCGFSZSA-N 0.000 claims 1
- KHTBWQBXLUSKSC-NWDGAFQWSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-[(2r,5s)-2,5-dimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN[C@@H](C)CN1C1=CC=C(C=C(C=2SC3=CC=CC(Cl)=C3N=2)C(=O)O2)C2=N1 KHTBWQBXLUSKSC-NWDGAFQWSA-N 0.000 claims 1
- RFUOLDFXNKIEGC-BETUJISGSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-[(3r,5s)-3,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N(C)[C@@H](C)CN1C1=CC=C(C=C(C=2SC3=CC=CC(Cl)=C3N=2)C(=O)O2)C2=N1 RFUOLDFXNKIEGC-BETUJISGSA-N 0.000 claims 1
- ROAYKBBVDRJLKH-TXEJJXNPSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(C=2SC3=CC=CC(Cl)=C3N=2)C(=O)O2)C2=N1 ROAYKBBVDRJLKH-TXEJJXNPSA-N 0.000 claims 1
- SNCQHCWZEIVPHD-UHFFFAOYSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-[4-(2,3-dihydroxypropyl)piperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(CC(O)CO)CCN1C1=CC=C(C=C(C=2SC3=CC=CC(Cl)=C3N=2)C(=O)O2)C2=N1 SNCQHCWZEIVPHD-UHFFFAOYSA-N 0.000 claims 1
- YEEMOJGNZBIFLY-UHFFFAOYSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-[4-(2-hydroxyethyl)piperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound ClC1=CC=CC2=C1N=C(S2)C1=CC=2C(=NC(=CC=2)N2CCN(CC2)CCO)OC1=O YEEMOJGNZBIFLY-UHFFFAOYSA-N 0.000 claims 1
- GFMPXGSGBRHPCR-UHFFFAOYSA-N 3-(4-chloro-1,3-benzothiazol-2-yl)-7-[4-[(2-hydroxyphenyl)methyl]piperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound OC1=CC=CC=C1CN1CCN(C=2N=C3OC(=O)C(C=4SC5=CC=CC(Cl)=C5N=4)=CC3=CC=2)CC1 GFMPXGSGBRHPCR-UHFFFAOYSA-N 0.000 claims 1
- HRSKYOMHKBUZOR-UHFFFAOYSA-N 3-(4-methyl-1,3-thiazol-2-yl)-7-(4-propylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(CCC)CCN1C1=CC=C(C=C(C=2SC=C(C)N=2)C(=O)O2)C2=N1 HRSKYOMHKBUZOR-UHFFFAOYSA-N 0.000 claims 1
- PMOVLNOABYLSBD-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(4-ethyl-1,4-diazepan-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(CC)CCCN1C1=CC=C(C=C(C=2N=C3C(C)=NC(C)=CN3C=2)C(=O)O2)C2=N1 PMOVLNOABYLSBD-UHFFFAOYSA-N 0.000 claims 1
- NNOVYROVMQTVAI-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(4-ethylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(CC)CCN1C1=CC=C(C=C(C=2N=C3C(C)=NC(C)=CN3C=2)C(=O)O2)C2=N1 NNOVYROVMQTVAI-UHFFFAOYSA-N 0.000 claims 1
- DJSZNVQUJXGOOW-UHFFFAOYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-(4-methyl-1,4-diazepan-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)CCCN1C1=CC=C(C=C(C=2N=C3C(C)=NC(C)=CN3C=2)C(=O)O2)C2=N1 DJSZNVQUJXGOOW-UHFFFAOYSA-N 0.000 claims 1
- HEINBMZDPIDHTD-LSDHHAIUSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(2R,5S)-2,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@H]1CN([C@H](C)CN1C)c1ccc2cc(-c3cn4cc(C)nc(C)c4n3)c(=O)oc2n1 HEINBMZDPIDHTD-LSDHHAIUSA-N 0.000 claims 1
- JEWJHHACJBFGJE-GXTWGEPZSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(2r,5s)-2,5-dimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(C)=NC(C)=CN3C=2)C(=O)O2)C2=N1 JEWJHHACJBFGJE-GXTWGEPZSA-N 0.000 claims 1
- OZUYPLDKSGKMQU-BETUJISGSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(C)=NC(C)=CN3C=2)C(=O)O2)C2=N1 OZUYPLDKSGKMQU-BETUJISGSA-N 0.000 claims 1
- ANJFEQMZMBVYNA-HNNXBMFYSA-N 3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-7-[(3s)-4-ethyl-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@H](C)N(CC)CCN1C1=CC=C(C=C(C=2N=C3C(C)=NC(C)=CN3C=2)C(=O)O2)C2=N1 ANJFEQMZMBVYNA-HNNXBMFYSA-N 0.000 claims 1
- KYMOWWWPEHHYIX-LSDHHAIUSA-N 3-(6-methylimidazo[1,2-a]pyrazin-2-yl)-7-[(2r,5s)-2,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=NC(C)=CN3C=2)C(=O)O2)C2=N1 KYMOWWWPEHHYIX-LSDHHAIUSA-N 0.000 claims 1
- GGMRXOWQPZZHHO-UHFFFAOYSA-N 3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-(4-methylpiperazin-1-yl)pyrano[3,2-c]pyridin-2-one Chemical compound C1CN(C)CCN1C(N=C1)=CC2=C1C=C(C=1N=C3C=CC(C)=CN3C=1)C(=O)O2 GGMRXOWQPZZHHO-UHFFFAOYSA-N 0.000 claims 1
- JNFNOQFFVAXVKY-JKSUJKDBSA-N 3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-[(2r,5s)-2,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC(C)=CN3C=2)C(=O)O2)C2=N1 JNFNOQFFVAXVKY-JKSUJKDBSA-N 0.000 claims 1
- IESPAQZDKIVXCY-CQSZACIVSA-N 3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-[(3r)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN[C@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC(C)=CN3C=2)C(=O)O2)C2=N1 IESPAQZDKIVXCY-CQSZACIVSA-N 0.000 claims 1
- IESPAQZDKIVXCY-AWEZNQCLSA-N 3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC(C)=CN3C=2)C(=O)O2)C2=N1 IESPAQZDKIVXCY-AWEZNQCLSA-N 0.000 claims 1
- PXJMYTGWBSPLGE-UHFFFAOYSA-N 3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylpyrano[3,2-c]pyridin-2-one Chemical compound C=1N2C=C(C)C=CC2=NC=1C(C(OC1=C2)=O)=CC1=CN=C2N1CCNCC1 PXJMYTGWBSPLGE-UHFFFAOYSA-N 0.000 claims 1
- JPFANBVVRYMOOP-UHFFFAOYSA-N 3-(7-methylimidazo[1,2-a]pyridin-2-yl)-7-(4-methylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(C=2N=C3C=C(C)C=CN3C=2)C(=O)O2)C2=N1 JPFANBVVRYMOOP-UHFFFAOYSA-N 0.000 claims 1
- MYGRPGGGVVBNHO-JKSUJKDBSA-N 3-(7-methylimidazo[1,2-a]pyridin-2-yl)-7-[(2r,5s)-2,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=C(C)C=CN3C=2)C(=O)O2)C2=N1 MYGRPGGGVVBNHO-JKSUJKDBSA-N 0.000 claims 1
- ZCRFKGQPOWYMOL-AWEZNQCLSA-N 3-(7-methylimidazo[1,2-a]pyridin-2-yl)-7-[(2s)-2-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@H]1CNCCN1C1=CC=C(C=C(C=2N=C3C=C(C)C=CN3C=2)C(=O)O2)C2=N1 ZCRFKGQPOWYMOL-AWEZNQCLSA-N 0.000 claims 1
- XMZFXZSRQASUTH-AWEZNQCLSA-N 3-(7-methylimidazo[1,2-a]pyridin-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=C(C)C=CN3C=2)C(=O)O2)C2=N1 XMZFXZSRQASUTH-AWEZNQCLSA-N 0.000 claims 1
- YUMOYINVWIVTGQ-UHFFFAOYSA-N 3-(7-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylpyrano[2,3-b]pyridin-2-one;hydrochloride Chemical compound Cl.N1=C2C=C(C)C=CN2C=C1C(C(OC1=N2)=O)=CC1=CC=C2N1CCNCC1 YUMOYINVWIVTGQ-UHFFFAOYSA-N 0.000 claims 1
- QHLFDKRADNKWLQ-UHFFFAOYSA-N 3-(7-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylpyrano[3,2-c]pyridin-2-one;hydrochloride Chemical compound Cl.N1=C2C=C(C)C=CN2C=C1C(C(OC1=C2)=O)=CC1=CN=C2N1CCNCC1 QHLFDKRADNKWLQ-UHFFFAOYSA-N 0.000 claims 1
- MPSOEGBAEWEKTC-UHFFFAOYSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-(4-ethyl-1,4-diazepan-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(CC)CCCN1C1=CC=C(C=C(C=2N=C3C(Cl)=CC=CN3C=2)C(=O)O2)C2=N1 MPSOEGBAEWEKTC-UHFFFAOYSA-N 0.000 claims 1
- ZJUZCAGDZXJODA-UHFFFAOYSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-(4-ethylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CCN1CCN(CC1)c1ccc2cc(-c3cn4cccc(Cl)c4n3)c(=O)oc2n1 ZJUZCAGDZXJODA-UHFFFAOYSA-N 0.000 claims 1
- RWTINPPSNQBARR-UONOGXRCSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-[(2r,5s)-2,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(Cl)=CC=CN3C=2)C(=O)O2)C2=N1 RWTINPPSNQBARR-UONOGXRCSA-N 0.000 claims 1
- BCBJLTTVGXGMKN-QWHCGFSZSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-[(2r,5s)-2,5-dimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(Cl)=CC=CN3C=2)C(=O)O2)C2=N1 BCBJLTTVGXGMKN-QWHCGFSZSA-N 0.000 claims 1
- LKDMRPOMNKQVED-OKILXGFUSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-[(3R,5S)-3,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound ClC=1C=2N(C=CC=1)C=C(N=2)C1=CC=2C(=NC(=CC=2)N2C[C@H](N([C@H](C2)C)C)C)OC1=O LKDMRPOMNKQVED-OKILXGFUSA-N 0.000 claims 1
- OLFZQCXJABDFBW-BETUJISGSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(Cl)=CC=CN3C=2)C(=O)O2)C2=N1 OLFZQCXJABDFBW-BETUJISGSA-N 0.000 claims 1
- MJYMJSWICZQZDF-AWEZNQCLSA-N 3-(8-chloroimidazo[1,2-a]pyridin-2-yl)-7-[(3s)-4-ethyl-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@H](C)N(CC)CCN1C1=CC=C(C=C(C=2N=C3C(Cl)=CC=CN3C=2)C(=O)O2)C2=N1 MJYMJSWICZQZDF-AWEZNQCLSA-N 0.000 claims 1
- CLHBXYWHKZYNSU-UHFFFAOYSA-N 3-(8-fluoro-6-methylimidazo[1,2-a]pyridin-2-yl)-7-(4-methyl-1,4-diazepan-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound FC=1C=2N(C=C(C=1)C)C=C(N=2)C1=CC=2C(=NC(=CC=2)N2CCN(CCC2)C)OC1=O CLHBXYWHKZYNSU-UHFFFAOYSA-N 0.000 claims 1
- BAFJYLHYVNWFII-UHFFFAOYSA-N 3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)-7-(4-methyl-1,4-diazepan-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)CCCN1C1=CC=C(C=C(C=2N=C3C(F)=CC=CN3C=2)C(=O)O2)C2=N1 BAFJYLHYVNWFII-UHFFFAOYSA-N 0.000 claims 1
- BRUJHKOAXZXPMB-UHFFFAOYSA-N 3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)-7-(4-methylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CN1CCN(CC1)c1ccc2cc(-c3cn4cccc(F)c4n3)c(=O)oc2n1 BRUJHKOAXZXPMB-UHFFFAOYSA-N 0.000 claims 1
- VFSSNTHXSIRGRV-UONOGXRCSA-N 3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)-7-[(2r,5s)-2,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(F)=CC=CN3C=2)C(=O)O2)C2=N1 VFSSNTHXSIRGRV-UONOGXRCSA-N 0.000 claims 1
- PSIFJIDLKUTWIO-LBPRGKRZSA-N 3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)-7-[(2s)-2-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@H]1CNCCN1C1=CC=C(C=C(C=2N=C3C(F)=CC=CN3C=2)C(=O)O2)C2=N1 PSIFJIDLKUTWIO-LBPRGKRZSA-N 0.000 claims 1
- FTTVRBRIVZWOPS-OKILXGFUSA-N 3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)-7-[(3R,5S)-3,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@H]1CN(C[C@@H](C)N1C)c1ccc2cc(-c3cn4cccc(F)c4n3)c(=O)oc2n1 FTTVRBRIVZWOPS-OKILXGFUSA-N 0.000 claims 1
- GZPYXAMOKAQBMJ-LBPRGKRZSA-N 3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)-7-[(3s)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(F)=CC=CN3C=2)C(=O)O2)C2=N1 GZPYXAMOKAQBMJ-LBPRGKRZSA-N 0.000 claims 1
- IKMDPBZUQVVVEK-UHFFFAOYSA-N 3-imidazo[1,2-a]pyridin-2-yl-7-(4-methyl-1,4-diazepan-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)CCCN1C1=CC=C(C=C(C=2N=C3C=CC=CN3C=2)C(=O)O2)C2=N1 IKMDPBZUQVVVEK-UHFFFAOYSA-N 0.000 claims 1
- UAOFDBZJMULGTC-GASCZTMLSA-N 3-imidazo[1,2-a]pyridin-2-yl-7-[(3S,5R)-3,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound N=1C(=CN2C=1C=CC=C2)C1=CC=2C(=NC(=CC=2)N2C[C@H](N([C@H](C2)C)C)C)OC1=O UAOFDBZJMULGTC-GASCZTMLSA-N 0.000 claims 1
- SRGAJSFEMHPNGS-CYBMUJFWSA-N 3-imidazo[1,2-a]pyridin-2-yl-7-[(3r)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN[C@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC=CN3C=2)C(=O)O2)C2=N1 SRGAJSFEMHPNGS-CYBMUJFWSA-N 0.000 claims 1
- SZILQYFKDBLWOB-BTQNPOSSSA-N 3-imidazo[1,2-a]pyridin-2-yl-7-[(3r)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one;hydrochloride Chemical compound Cl.C1CN[C@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC=CN3C=2)C(=O)O2)C2=N1 SZILQYFKDBLWOB-BTQNPOSSSA-N 0.000 claims 1
- SRGAJSFEMHPNGS-ZDUSSCGKSA-N 3-imidazo[1,2-a]pyridin-2-yl-7-[(3s)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC=CN3C=2)C(=O)O2)C2=N1 SRGAJSFEMHPNGS-ZDUSSCGKSA-N 0.000 claims 1
- GMHHNJGSGLOCHX-UHFFFAOYSA-N 3-imidazo[1,2-a]pyridin-2-yl-7-piperazin-1-ylpyrano[3,2-c]pyridin-2-one 3-(5-methylpyrazolo[1,5-a]pyridin-2-yl)-7-piperazin-1-ylpyrano[2,3-b]pyridin-2-one Chemical compound CC1=CC2=CC(=NN2C=C1)C3=CC4=C(N=C(C=C4)N5CCNCC5)OC3=O.C1CN(CCN1)C2=NC=C3C=C(C(=O)OC3=C2)C4=CN5C=CC=CC5=N4 GMHHNJGSGLOCHX-UHFFFAOYSA-N 0.000 claims 1
- XCPQAHZZXHVKJL-UHFFFAOYSA-N 3-imidazo[1,2-a]pyrimidin-2-yl-7-(4-methylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound N=1C(=CN2C=1N=CC=C2)C1=CC=2C(=NC(=CC=2)N2CCN(CC2)C)OC1=O XCPQAHZZXHVKJL-UHFFFAOYSA-N 0.000 claims 1
- OQWCNLZGMUXIPF-OKILXGFUSA-N 3-imidazo[1,2-a]pyrimidin-2-yl-7-[(3R,5S)-3,4,5-trimethylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C[C@H]1CN(C[C@@H](C)N1C)c1ccc2cc(-c3cn4cccnc4n3)c(=O)oc2n1 OQWCNLZGMUXIPF-OKILXGFUSA-N 0.000 claims 1
- CUDLQBVFNTTZCL-UHFFFAOYSA-N 3-imidazo[2,1-b][1,3]thiazol-6-yl-7-(4-methyl-1,4-diazepan-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)CCCN1C1=CC=C(C=C(C=2N=C3SC=CN3C=2)C(=O)O2)C2=N1 CUDLQBVFNTTZCL-UHFFFAOYSA-N 0.000 claims 1
- OSCIOPPNBUSYOB-UHFFFAOYSA-N 3-imidazo[2,1-b][1,3]thiazol-6-yl-7-(4-methylpiperazin-1-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)CCN1C1=CC=C(C=C(C=2N=C3SC=CN3C=2)C(=O)O2)C2=N1 OSCIOPPNBUSYOB-UHFFFAOYSA-N 0.000 claims 1
- QZWOTHFUDTXROU-LLVKDONJSA-N 3-imidazo[2,1-b][1,3]thiazol-6-yl-7-[(3r)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN[C@H](C)CN1C1=CC=C(C=C(C=2N=C3SC=CN3C=2)C(=O)O2)C2=N1 QZWOTHFUDTXROU-LLVKDONJSA-N 0.000 claims 1
- QZWOTHFUDTXROU-NSHDSACASA-N 3-imidazo[2,1-b][1,3]thiazol-6-yl-7-[(3s)-3-methylpiperazin-1-yl]pyrano[2,3-b]pyridin-2-one Chemical compound C1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3SC=CN3C=2)C(=O)O2)C2=N1 QZWOTHFUDTXROU-NSHDSACASA-N 0.000 claims 1
- CHXRIRRICPPGIU-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound N1=C2C(C)=NC(C)=CN2C=C1C(C(OC1=N2)=O)=CC1=CC=C2N1CCCNCC1 CHXRIRRICPPGIU-UHFFFAOYSA-N 0.000 claims 1
- VPKHXWDMSJQUSG-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one;hydrochloride Chemical compound Cl.N1=C2C(C)=NC(C)=CN2C=C1C(C(OC1=N2)=O)=CC1=CC=C2N1CCCNCC1 VPKHXWDMSJQUSG-UHFFFAOYSA-N 0.000 claims 1
- KPUQNPSBRQAJDC-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound N1=C2C=NC(C)=CN2C=C1C(C(OC1=N2)=O)=CC1=CC=C2N1CCCNCC1 KPUQNPSBRQAJDC-UHFFFAOYSA-N 0.000 claims 1
- UZRRVTFDEUABOI-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one;hydrochloride Chemical compound Cl.N1=C2C=NC(C)=CN2C=C1C(C(OC1=N2)=O)=CC1=CC=C2N1CCCNCC1 UZRRVTFDEUABOI-UHFFFAOYSA-N 0.000 claims 1
- RTQGNINELUHECF-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-(8-fluoro-6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C=1N2C=C(C)C=C(F)C2=NC=1C(C(OC1=N2)=O)=CC1=CC=C2N1CCCNCC1 RTQGNINELUHECF-UHFFFAOYSA-N 0.000 claims 1
- JOVQGPURTKDKCW-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-(8-fluoro-6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one;hydrochloride Chemical compound Cl.C=1N2C=C(C)C=C(F)C2=NC=1C(C(OC1=N2)=O)=CC1=CC=C2N1CCCNCC1 JOVQGPURTKDKCW-UHFFFAOYSA-N 0.000 claims 1
- OLLQJERRXIGGRF-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one hydrochloride Chemical compound Cl.Fc1cccn2cc(nc12)-c1cc2ccc(nc2oc1=O)N1CCCNCC1 OLLQJERRXIGGRF-UHFFFAOYSA-N 0.000 claims 1
- PERKUSDCGSKHRX-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-imidazo[1,2-a]pyridin-2-ylpyrano[2,3-b]pyridin-2-one;3-imidazo[2,1-b][1,3]thiazol-6-yl-7-piperazin-1-ylpyrano[2,3-b]pyridin-2-one Chemical compound C1=CC=2C=C(C=3N=C4SC=CN4C=3)C(=O)OC=2N=C1N1CCNCC1.C1=CC=2C=C(C=3N=C4C=CC=CN4C=3)C(=O)OC=2N=C1N1CCCNCC1 PERKUSDCGSKHRX-UHFFFAOYSA-N 0.000 claims 1
- ZQKWGTJVNOOWDA-UHFFFAOYSA-N 7-(1,4-diazepan-1-yl)-3-imidazo[1,2-a]pyridin-2-ylpyrano[2,3-b]pyridin-2-one;hydrochloride Chemical compound Cl.C1=CC=2C=C(C=3N=C4C=CC=CN4C=3)C(=O)OC=2N=C1N1CCCNCC1 ZQKWGTJVNOOWDA-UHFFFAOYSA-N 0.000 claims 1
- SKOYRROKKOYJCL-UHFFFAOYSA-N 7-(4-ethyl-1,4-diazepan-1-yl)-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C(C)N1CCN(CCC1)C1=CC=C2C(=N1)OC(C(=C2)C=1N=C2N(C=C(N=C2)C)C=1)=O SKOYRROKKOYJCL-UHFFFAOYSA-N 0.000 claims 1
- VMRIGBAADKCNSJ-UHFFFAOYSA-N 7-(4-ethyl-1,4-diazepan-1-yl)-3-(8-fluoro-6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CCN1CCCN(CC1)c1ccc2cc(-c3cn4cc(C)cc(F)c4n3)c(=O)oc2n1 VMRIGBAADKCNSJ-UHFFFAOYSA-N 0.000 claims 1
- KEZFRHHQNURTDX-UHFFFAOYSA-N 7-(4-ethyl-1,4-diazepan-1-yl)-3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C(C)N1CCN(CCC1)C1=CC=C2C(=N1)OC(C(=C2)C=1N=C2N(C=CC=C2F)C=1)=O KEZFRHHQNURTDX-UHFFFAOYSA-N 0.000 claims 1
- AAMDCFVCKOYINH-UHFFFAOYSA-N 7-(4-ethyl-1,4-diazepan-1-yl)-3-imidazo[1,2-a]pyridin-2-ylpyrano[2,3-b]pyridin-2-one Chemical compound C1CN(CC)CCCN1C1=CC=C(C=C(C=2N=C3C=CC=CN3C=2)C(=O)O2)C2=N1 AAMDCFVCKOYINH-UHFFFAOYSA-N 0.000 claims 1
- DGKQMLLJQYHGJJ-UHFFFAOYSA-N 7-(4-ethylpiperazin-1-yl)-3-(7-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CCN1CCN(CC1)c1ccc2cc(-c3cn4ccc(C)cc4n3)c(=O)oc2n1 DGKQMLLJQYHGJJ-UHFFFAOYSA-N 0.000 claims 1
- ZXQBXQMZDNSKRV-UHFFFAOYSA-N 7-(4-ethylpiperazin-1-yl)-3-(8-fluoro-6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CCN1CCN(CC1)c1ccc2cc(-c3cn4cc(C)cc(F)c4n3)c(=O)oc2n1 ZXQBXQMZDNSKRV-UHFFFAOYSA-N 0.000 claims 1
- IMMRLWUDLMKITM-UHFFFAOYSA-N 7-(4-ethylpiperazin-1-yl)-3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CCN1CCN(CC1)c1ccc2cc(-c3cn4cccc(F)c4n3)c(=O)oc2n1 IMMRLWUDLMKITM-UHFFFAOYSA-N 0.000 claims 1
- ZPOPYGJKRXVMRH-UHFFFAOYSA-N 7-(4-methyl-1,4-diazepan-1-yl)-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CN1CCCN(CC1)c1ccc2cc(-c3cn4cc(C)ncc4n3)c(=O)oc2n1 ZPOPYGJKRXVMRH-UHFFFAOYSA-N 0.000 claims 1
- JZMHQTXLUOPDMH-UHFFFAOYSA-N 7-(4-methyl-1,4-diazepan-1-yl)-3-(6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CN1CCN(CCC1)C1=CC=C2C(=N1)OC(C(=C2)C=1N=C2N(C=C(C=C2)C)C=1)=O JZMHQTXLUOPDMH-UHFFFAOYSA-N 0.000 claims 1
- IHJYNCKCJUELBJ-UHFFFAOYSA-N 7-(4-methyl-1,4-diazepan-1-yl)-3-(7-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)CCCN1C1=CC=C(C=C(C=2N=C3C=C(C)C=CN3C=2)C(=O)O2)C2=N1 IHJYNCKCJUELBJ-UHFFFAOYSA-N 0.000 claims 1
- DWRWHUFMVCPDEK-UONOGXRCSA-N 7-[(2R,5S)-2,5-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C[C@H]1N(C[C@@H](NC1)C)C1=CC=C2C(=N1)OC(C(=C2)C=1N=C2N(C=C(N=C2)C)C=1)=O DWRWHUFMVCPDEK-UONOGXRCSA-N 0.000 claims 1
- WATUEUDATSCBKI-UONOGXRCSA-N 7-[(2R,5S)-2,5-dimethylpiperazin-1-yl]-3-(8-fluoro-6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C[C@H]1CN([C@H](C)CN1)c1ccc2cc(-c3cn4cc(C)cc(F)c4n3)c(=O)oc2n1 WATUEUDATSCBKI-UONOGXRCSA-N 0.000 claims 1
- RWWPHSLTMMPNNF-LSDHHAIUSA-N 7-[(2r,5s)-2,5-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC(C)=CN3C=2)C(=O)O2)C2=N1 RWWPHSLTMMPNNF-LSDHHAIUSA-N 0.000 claims 1
- OIAWUWPDEPQEJW-LSDHHAIUSA-N 7-[(2r,5s)-2,5-dimethylpiperazin-1-yl]-3-(7-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=C(C)C=CN3C=2)C(=O)O2)C2=N1 OIAWUWPDEPQEJW-LSDHHAIUSA-N 0.000 claims 1
- LJCXGIFUMVFIMZ-QWHCGFSZSA-N 7-[(2r,5s)-2,5-dimethylpiperazin-1-yl]-3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(F)=CC=CN3C=2)C(=O)O2)C2=N1 LJCXGIFUMVFIMZ-QWHCGFSZSA-N 0.000 claims 1
- GUKZWIZTIYJNSI-HNNXBMFYSA-N 7-[(2s)-2,4-dimethylpiperazin-1-yl]-3-(7-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C[C@H]1CN(C)CCN1C1=CC=C(C=C(C=2N=C3C=C(C)C=CN3C=2)C(=O)O2)C2=N1 GUKZWIZTIYJNSI-HNNXBMFYSA-N 0.000 claims 1
- ZFQZBXKKSZNJFJ-OKILXGFUSA-N 7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C[C@@H]1CN(C[C@@H](N1)C)C1=CC=C2C(=N1)OC(C(=C2)C=1N=C2N(C=C(N=C2)C)C=1)=O ZFQZBXKKSZNJFJ-OKILXGFUSA-N 0.000 claims 1
- HIHSTYLBOMSGGO-HNNXBMFYSA-N 7-[(3S)-4-ethyl-3-methylpiperazin-1-yl]-3-(8-fluoro-6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound CCN1CCN(C[C@@H]1C)c1ccc2cc(-c3cn4cc(C)cc(F)c4n3)c(=O)oc2n1 HIHSTYLBOMSGGO-HNNXBMFYSA-N 0.000 claims 1
- HGWXQSAEFMPFTE-OAHLLOKOSA-N 7-[(3r)-3,4-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)[C@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC(C)=CN3C=2)C(=O)O2)C2=N1 HGWXQSAEFMPFTE-OAHLLOKOSA-N 0.000 claims 1
- KQNGAQLMGJJHMG-CQSZACIVSA-N 7-[(3r)-3,4-dimethylpiperazin-1-yl]-3-imidazo[1,2-a]pyridin-2-ylpyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)[C@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC=CN3C=2)C(=O)O2)C2=N1 KQNGAQLMGJJHMG-CQSZACIVSA-N 0.000 claims 1
- VBDGQDKIWQBGAM-GASCZTMLSA-N 7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC(C)=CN3C=2)C(=O)O2)C2=N1 VBDGQDKIWQBGAM-GASCZTMLSA-N 0.000 claims 1
- NQZPKBFGGTXWJQ-BETUJISGSA-N 7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-3-(8-fluoroimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(F)=CC=CN3C=2)C(=O)O2)C2=N1 NQZPKBFGGTXWJQ-BETUJISGSA-N 0.000 claims 1
- NVWOXBHQEWTUAL-OKILXGFUSA-N 7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-3-imidazo[1,2-a]pyridin-2-ylpyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC=CN3C=2)C(=O)O2)C2=N1 NVWOXBHQEWTUAL-OKILXGFUSA-N 0.000 claims 1
- PUWGZSJJDJLITM-BETUJISGSA-N 7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-3-imidazo[1,2-a]pyrimidin-2-ylpyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3N=CC=CN3C=2)C(=O)O2)C2=N1 PUWGZSJJDJLITM-BETUJISGSA-N 0.000 claims 1
- HGWXQSAEFMPFTE-HNNXBMFYSA-N 7-[(3s)-3,4-dimethylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC(C)=CN3C=2)C(=O)O2)C2=N1 HGWXQSAEFMPFTE-HNNXBMFYSA-N 0.000 claims 1
- XHQVWUYYYYJYSN-HNNXBMFYSA-N 7-[(3s)-3,4-dimethylpiperazin-1-yl]-3-(7-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=C(C)C=CN3C=2)C(=O)O2)C2=N1 XHQVWUYYYYJYSN-HNNXBMFYSA-N 0.000 claims 1
- KQNGAQLMGJJHMG-AWEZNQCLSA-N 7-[(3s)-3,4-dimethylpiperazin-1-yl]-3-imidazo[1,2-a]pyridin-2-ylpyrano[2,3-b]pyridin-2-one Chemical compound C1CN(C)[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C=CC=CN3C=2)C(=O)O2)C2=N1 KQNGAQLMGJJHMG-AWEZNQCLSA-N 0.000 claims 1
- LDZVSIMXBCHMSK-HNNXBMFYSA-N 7-[(3s)-4-ethyl-3-methylpiperazin-1-yl]-3-(6-methylimidazo[1,2-a]pyrazin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@H](C)N(CC)CCN1C1=CC=C(C=C(C=2N=C3C=NC(C)=CN3C=2)C(=O)O2)C2=N1 LDZVSIMXBCHMSK-HNNXBMFYSA-N 0.000 claims 1
- MBCLAMDKFDJPMT-OKILXGFUSA-N 7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-3-(8-fluoro-6-methylimidazo[1,2-a]pyridin-2-yl)pyrano[2,3-b]pyridin-2-one Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C(C=C(C=2N=C3C(F)=CC(C)=CN3C=2)C(=O)O2)C2=N1 MBCLAMDKFDJPMT-OKILXGFUSA-N 0.000 claims 1
- LGJDHASTUUIZEN-UHFFFAOYSA-N 7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]pyrano[2,3-b]pyridin-2-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=CSC(C=2C(OC3=NC(=CC=C3C=2)N2CCNCC2)=O)=N1 LGJDHASTUUIZEN-UHFFFAOYSA-N 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- OEMBRVSANKBOKA-UHFFFAOYSA-N CC(C)(C)C(C(C=NC(N1CCNCC1)=C1)=C1O1)=C(C2=NC(C(Cl)=CC=C3)=C3S2)C1=O Chemical compound CC(C)(C)C(C(C=NC(N1CCNCC1)=C1)=C1O1)=C(C2=NC(C(Cl)=CC=C3)=C3S2)C1=O OEMBRVSANKBOKA-UHFFFAOYSA-N 0.000 claims 1
- IODIAAWMHNUXJC-UHFFFAOYSA-N CC1=CC=2N(C=C1)N=C(C2)C2=CC=1C(=NC(=CC1)N1CCNCC1)OC2=O.Cl.N=2C(=CN1C2C=CC=C1)C1=CC=2C=NC(=CC2OC1=O)N1CCNCC1 Chemical compound CC1=CC=2N(C=C1)N=C(C2)C2=CC=1C(=NC(=CC1)N1CCNCC1)OC2=O.Cl.N=2C(=CN1C2C=CC=C1)C1=CC=2C=NC(=CC2OC1=O)N1CCNCC1 IODIAAWMHNUXJC-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- YXMBVEGCNUAXEN-UHFFFAOYSA-N Cl.CC=1N=C(SC1)C1=CC=2C(=NC(=CC2)N2CCNCC2)OC1=O.Cl Chemical compound Cl.CC=1N=C(SC1)C1=CC=2C(=NC(=CC2)N2CCNCC2)OC1=O.Cl YXMBVEGCNUAXEN-UHFFFAOYSA-N 0.000 claims 1
- NLMNEKWHDXMWFL-UHFFFAOYSA-N Cl.N=1C(=CN2C1C=CC=C2)C2=CC=1C(=NC(=CC1)N1CCNCC1)OC2=O.Cl Chemical compound Cl.N=1C(=CN2C1C=CC=C2)C2=CC=1C(=NC(=CC1)N1CCNCC1)OC2=O.Cl NLMNEKWHDXMWFL-UHFFFAOYSA-N 0.000 claims 1
- SKVNOBJYAHILFI-UHFFFAOYSA-N Cl.S1C(=NC2=C1C=CC=C2)C2=CC=1C(=NC(=CC1)N1CCNCCC1)OC2=O.Cl Chemical compound Cl.S1C(=NC2=C1C=CC=C2)C2=CC=1C(=NC(=CC1)N1CCNCCC1)OC2=O.Cl SKVNOBJYAHILFI-UHFFFAOYSA-N 0.000 claims 1
- VBZUUCFDKYNOAM-UHFFFAOYSA-N Cl.S1C=2N(C=C1)C=C(N2)C2=CC=1C(=NC(=CC1)N1CCNCC1)OC2=O.Cl Chemical compound Cl.S1C=2N(C=C1)C=C(N2)C2=CC=1C(=NC(=CC1)N1CCNCC1)OC2=O.Cl VBZUUCFDKYNOAM-UHFFFAOYSA-N 0.000 claims 1
- PVKQAHVIJVFRJS-UHFFFAOYSA-N ClC1=CC=CC2=C1N=C(S2)C2=CC=1C(=NC(=CC1)N1CCNCCC1)OC2=O.Cl.N2(CCNCCC2)C2=CC=C1C(=N2)OC(C(=C1)C=1N=C2N(C=CC=N2)C1)=O Chemical compound ClC1=CC=CC2=C1N=C(S2)C2=CC=1C(=NC(=CC1)N1CCNCCC1)OC2=O.Cl.N2(CCNCCC2)C2=CC=C1C(=N2)OC(C(=C1)C=1N=C2N(C=CC=N2)C1)=O PVKQAHVIJVFRJS-UHFFFAOYSA-N 0.000 claims 1
- LURCMBNAKAGKAH-UHFFFAOYSA-N ClC1=CC=CC2=C1N=C(S2)C2=CC=1C=NC(=CC1OC2=O)N2CCNCC2.Cl.ClC2=CC=CC1=C2N=C(S1)C1=CC=2C(=NC(=CC2)N2CCNCC2)OC1=O Chemical group ClC1=CC=CC2=C1N=C(S2)C2=CC=1C=NC(=CC1OC2=O)N2CCNCC2.Cl.ClC2=CC=CC1=C2N=C(S1)C1=CC=2C(=NC(=CC2)N2CCNCC2)OC1=O LURCMBNAKAGKAH-UHFFFAOYSA-N 0.000 claims 1
- 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 claims 1
- 101150015954 SMN2 gene Proteins 0.000 claims 1
- 102100021947 Survival motor neuron protein Human genes 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261605487P | 2012-03-01 | 2012-03-01 | |
| US61/605,487 | 2012-03-01 | ||
| PCT/US2013/028131 WO2013130689A1 (en) | 2012-03-01 | 2013-02-28 | Compounds for treating spinal muscular atrophy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015509956A JP2015509956A (ja) | 2015-04-02 |
| JP2015509956A5 true JP2015509956A5 (https=) | 2016-03-17 |
| JP6092264B2 JP6092264B2 (ja) | 2017-03-08 |
Family
ID=49083256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014560007A Active JP6092264B2 (ja) | 2012-03-01 | 2013-02-28 | 脊髄性筋委縮症を処置するための化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9371336B2 (https=) |
| EP (1) | EP2819519B1 (https=) |
| JP (1) | JP6092264B2 (https=) |
| KR (1) | KR102099997B1 (https=) |
| CN (1) | CN104302181B (https=) |
| BR (1) | BR112014021531B1 (https=) |
| CA (1) | CA2865957C (https=) |
| EA (1) | EA029155B1 (https=) |
| MX (1) | MX352962B (https=) |
| WO (1) | WO2013130689A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX352861B (es) | 2011-12-30 | 2017-12-13 | Ptc Therapeutics Inc | Compuestos para tratar la atrofia muscular espinal. |
| MX357834B (es) | 2012-01-26 | 2018-07-26 | Ptc Therapeutics Inc | Compuestos de tipo isocumarina sustituidos para tratar la atrofia muscular espinal. |
| EP2812004B1 (en) | 2012-02-10 | 2018-06-27 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| CA2868026C (en) | 2012-03-23 | 2021-02-16 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| CA2894992A1 (en) * | 2012-12-24 | 2014-07-03 | Ramot At Tel-Aviv University Ltd. | Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same |
| EP3035935B1 (en) | 2013-08-19 | 2020-03-11 | F. Hoffmann-La Roche AG | Compounds for use in the prophylaxis and treatment of cancer |
| US10195202B2 (en) | 2013-12-19 | 2019-02-05 | Ptc Therapeutics, Inc. | Methods for modulating the amount of RNA transcripts |
| US10668171B2 (en) | 2015-05-30 | 2020-06-02 | Ptc Therapeutics, Inc. | Methods for modulating RNA splicing |
| EP3133065A1 (en) | 2015-08-21 | 2017-02-22 | Merck Patent GmbH | Compounds for optically active devices |
| EA201800367A1 (ru) | 2015-12-10 | 2019-02-28 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы лечения болезни хантингтона |
| JP2019535789A (ja) | 2016-11-28 | 2019-12-12 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｒｎａスプライシングを調節する方法 |
| EP3363786A1 (en) | 2017-02-15 | 2018-08-22 | Merck Patent GmbH | Compounds for optically active devices |
| EP3363793A1 (en) | 2017-02-15 | 2018-08-22 | Merck Patent GmbH | Hydrophobic compounds for optically active devices |
| EP3634953B1 (en) | 2017-06-05 | 2024-01-03 | PTC Therapeutics, Inc. | Compounds for treating huntington's disease |
| JP2020523365A (ja) | 2017-06-14 | 2020-08-06 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｒｎａスプライシングを改変する方法 |
| CN111182898B (zh) | 2017-06-28 | 2024-04-16 | Ptc医疗公司 | 用于治疗亨廷顿氏病的方法 |
| MX2019015580A (es) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics Inc | Metodos para tratar la enfermedad de huntington. |
| JP7312749B2 (ja) | 2017-08-04 | 2023-07-21 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングをモジュレートする方法および組成物 |
| EA202092001A1 (ru) | 2018-03-27 | 2021-01-29 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Соединения для лечения болезни гентингтона |
| CN112469707B (zh) | 2018-06-27 | 2024-06-21 | 利伯纳生物科学株式会社 | 脊髓性肌萎缩症的预防剂或治疗剂 |
| EP3814360B8 (en) | 2018-06-27 | 2024-11-06 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| HRP20240935T1 (hr) | 2018-06-27 | 2024-11-22 | Ptc Therapeutics, Inc. | Heterociklični i heteroaril spojevi za liječenje huntingtonove bolesti |
| WO2020005877A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| WO2020163405A1 (en) | 2019-02-05 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| JP7551629B2 (ja) | 2019-02-05 | 2024-09-17 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| JP7603595B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| JP7603594B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| JP7649257B2 (ja) | 2019-05-13 | 2025-03-19 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するための化合物 |
| US11129829B2 (en) | 2019-06-17 | 2021-09-28 | Skyhawk Therapeutics, Inc. | Methods for modulating splicing |
| CN111116460A (zh) * | 2019-12-31 | 2020-05-08 | 阿里生物新材料（常州）有限公司 | 一种2-氯-4-羟基吡啶-3-甲醛氢溴酸盐的合成方法 |
| JP7763397B2 (ja) | 2020-05-20 | 2025-11-04 | エイエムオー・アイルランド | 光学活性装置で使用するためのアザクマリン及びアザチオクマリン誘導体 |
| WO2023114539A1 (en) * | 2021-12-17 | 2023-06-22 | Pretzel Therapeutics, Inc. | Amino chromen-2-one modulators of polrmt |
| AU2024286618A1 (en) * | 2023-06-09 | 2025-10-30 | F. Hoffmann-La Roche Ag | Inducible gene expression system |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3558618A (en) | 1968-04-01 | 1971-01-26 | Dow Chemical Co | Novel 4h-pyrazino(1,2-a)pyrimidine-4-ones |
| US4122274A (en) | 1977-05-25 | 1978-10-24 | Bristol-Myers Company | 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones |
| US4342870A (en) | 1980-03-28 | 1982-08-03 | Janssen Pharmaceutica N.V. | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
| US5089633A (en) | 1987-04-28 | 1992-02-18 | Georgia Tech Research Corporation | Substituted isocoumarins |
| US5726182A (en) | 1990-05-02 | 1998-03-10 | Abbott Laboratories | Quinolizinone type compounds |
| AU4231293A (en) | 1992-05-13 | 1993-12-13 | E.I. Du Pont De Nemours And Company | Substituted pyrido(1,2-A)pyrimidinone derivatives as fungicides |
| US5597922A (en) * | 1994-07-29 | 1997-01-28 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Glycine receptor antagonist pharmacophore |
| US6630488B1 (en) | 1998-09-21 | 2003-10-07 | Biochem Pharma, Inc. | Quinolizinones as integrin inhibitors |
| EP1857443B1 (en) | 2000-01-24 | 2012-03-28 | AstraZeneca AB | Therapeutic morpholino-substituted compounds |
| GB0205281D0 (en) * | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
| WO2003104216A1 (en) | 2002-06-10 | 2003-12-18 | Acadia Pharmaceuticals Inc. | Urotensin ii receptor modulators |
| WO2004047766A2 (en) | 2002-11-25 | 2004-06-10 | Kaloidis Antonia C | Treatment for sma disease |
| US9068234B2 (en) | 2003-01-21 | 2015-06-30 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating gene expression |
| WO2004113335A2 (en) | 2003-06-20 | 2004-12-29 | Chiron Corporation | Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| US20050046698A1 (en) * | 2003-09-02 | 2005-03-03 | Knight Andrew Frederick | System and method for producing a selectable view of an object space |
| AU2004289303A1 (en) | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Fused heterocyclic compounds |
| ATE373659T1 (de) | 2004-05-04 | 2007-10-15 | Warner Lambert Co | Pyrrolylsubstituierte pyrido(2,3-d)pyrimidin-7- one und derivate davon als therapeutische mittel |
| WO2006045010A2 (en) | 2004-10-20 | 2006-04-27 | Resverlogix Corp. | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| CA2595477A1 (en) | 2005-01-21 | 2006-07-27 | Janssen Pharmaceutica N.V. | Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| WO2008013997A2 (en) | 2006-07-27 | 2008-01-31 | The Trustees Of Columbia University In The City Of New York | Fluorescent substrates for monoamine transporters as optical false neurotransmitters |
| US20100267712A1 (en) | 2007-09-27 | 2010-10-21 | The United States of America, as represented by the Secretary, Department of Health and | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| WO2009151546A2 (en) | 2008-05-27 | 2009-12-17 | Ptc Therapeutics, Inc. | Methods for treating spinal muscular atrophy |
| US8932818B2 (en) | 2008-08-13 | 2015-01-13 | Ptc Therapeutics, Inc. | Screening assays for compounds that modulate programmed ribosomal frameshifting |
| EP2501231B1 (en) | 2009-11-20 | 2016-12-21 | Merck Sharp & Dohme Corp. | Quinolizidinone carboxamide m1 receptor positive allosteric modulators |
| CN102812023A (zh) | 2010-01-13 | 2012-12-05 | 韩国巴斯德研究所 | 抗感染吡啶并(1,2-a)嘧啶类 |
| MX352861B (es) | 2011-12-30 | 2017-12-13 | Ptc Therapeutics Inc | Compuestos para tratar la atrofia muscular espinal. |
| MX357834B (es) | 2012-01-26 | 2018-07-26 | Ptc Therapeutics Inc | Compuestos de tipo isocumarina sustituidos para tratar la atrofia muscular espinal. |
| EP2812004B1 (en) | 2012-02-10 | 2018-06-27 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| CA2868026C (en) | 2012-03-23 | 2021-02-16 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
-
2013
- 2013-02-28 CA CA2865957A patent/CA2865957C/en active Active
- 2013-02-28 MX MX2014010406A patent/MX352962B/es active IP Right Grant
- 2013-02-28 JP JP2014560007A patent/JP6092264B2/ja active Active
- 2013-02-28 BR BR112014021531-6A patent/BR112014021531B1/pt active IP Right Grant
- 2013-02-28 EP EP13755032.3A patent/EP2819519B1/en active Active
- 2013-02-28 CN CN201380023259.1A patent/CN104302181B/zh active Active
- 2013-02-28 US US14/380,385 patent/US9371336B2/en active Active
- 2013-02-28 KR KR1020147027577A patent/KR102099997B1/ko active Active
- 2013-02-28 WO PCT/US2013/028131 patent/WO2013130689A1/en not_active Ceased
- 2013-02-28 EA EA201491617A patent/EA029155B1/ru not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509956A5 (https=) | ||
| JP2015511224A5 (https=) | ||
| JP7206314B2 (ja) | Ｊａｋ及びｐｉ３ｋ阻害剤併用によるｂ細胞悪性腫瘍の処置 | |
| ES2697174T3 (es) | Compuestos para tratar atrofia muscular espinal | |
| JP2015508075A5 (https=) | ||
| JP2015504057A5 (https=) | ||
| RU2012117796A (ru) | Производные пиразолиндиона как ингибиторы надфн-оксидазы | |
| RU2015124917A (ru) | Новые бициклические фенилпиридины/пиразины для лечения рака | |
| CA2783727A1 (en) | 2-arylimidazole derivatives as pde10a enzyme inhibitors | |
| RU2011116230A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| PE20170465A1 (es) | Agentes inductores de apoptosis para el tratamiento del cancer y de enfermedades inmunes y autoinmunes | |
| PE20120629A1 (es) | Compuesto triazolopiridina y su accion como inhibidor de prolil hidroxilasa e inductor de la produccion de eritropoyetina | |
| PE20120534A1 (es) | PIRIMIDINAS FUSIONADAS COMO INHIBIDORES DE Akt | |
| NZ600229A (en) | Triazolopyridines | |
| ME00972B (me) | NOVI DERIVATI 6-TRIAZOLOPIRIDAZINSULFANIL BENZOTIAZOLA I BENZIMIDAZOLA, POSTUPAK ZA NJIHOVO DOBIJANJE l UPOTREBA KAO LJEKOVA l FARMACEUTSKIH KOMPOZICIJA l NOVA UPOTREBA KAO INHIBITORA MET-a | |
| WO2015191506A3 (en) | Pyrrolo[2,3-c]pyridines as imaging agents for neurofibrilary tangles | |
| JP2017510564A5 (https=) | ||
| JP2011500774A5 (https=) | ||
| NZ577491A (en) | 2-heteroaryl-3-hydroxy-4-oxo-pyrido[1,2-a]pyrimidines and uses thereof | |
| HRP20151398T1 (hr) | Tricikliäśni derivati amina kao inhibitori protein tirozin kinaze | |
| WO2013147649A2 (ru) | ИНГИБИТОРЫ СИГНАЛЬНОГО ПУТИ PI3K/AKT/IKK/NF-kB, ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ВИРУСНЫХ ЗАБОЛЕВАНИЙ | |
| PH12015501836A1 (en) | 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoromet hyl)benzyl)quinazolin-4(3h)-one derivatives and their use as phosphoinositide 3-kinase inhibitors | |
| NZ611808A (en) | Compounds for treating respiratory syncytial virus infections | |
| DK3097083T3 (en) | BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| RU2013136778A (ru) | Ингибиторы гистондезацетилазы, композиции и способы их применения |